SCHEMBL21252155

SCHEMBL21252155

COc1cc(OC)c(Cl)c(-c2cc3cnc(N)cc3c(N3CCC(C#N)C3)n2)c1Cl

nearest known ligand 0.36

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ GAK O14976 1/20 0.36
▸ FGFR4 P22455 5/20 0.36
▸ NEK2 P51955 8/20 0.33
▸ TTK P33981 3/20 0.33
▸ LRRK2 Q5S007 1/20 0.33
▸ FGFR1 P11362 2/20 0.33
▸ FGFR2 P21802 1/20 0.33
▸ PLK1 P53350 1/20 0.32
▸ NEK1 Q96PY6 1/20 0.32
▸ PDE3B Q13370 1/20 0.32
▸ PDE3A Q14432 1/20 0.32
▸ PDE10A Q9Y233 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21240563 0.91 FGFR4 (0.35) GAKFGFR4TTKLRRK2FGFR1
SCHEMBL24488230 0.86 PDE10A (0.39) FGFR4NEK2FGFR1FGFR2PDE3B
SCHEMBL20332233 0.86 TTK (0.33) GAKFGFR4TTKLRRK2FGFR1
SCHEMBL21252449 0.85 TTK (0.38) GAKNEK2TTKLRRK2FGFR1
SCHEMBL21251928 0.85 GAK (0.38) GAKTTKLRRK2PDE3BPDE3A
SCHEMBL21252481 0.84 FGFR4 (0.40) FGFR4NEK2FGFR1FGFR2PLK1
SCHEMBL21252058 0.84 FGFR4 (0.40) FGFR4NEK2TTKFGFR1FGFR2
SCHEMBL21252087 0.83 MAP4K4 (0.39) FGFR4LRRK2FGFR1FGFR2PDE3B
SCHEMBL21252286 0.82 SMN1; SMN2 (0.40) FGFR4FGFR1FGFR2
SCHEMBL21252341 0.82 SMN1; SMN2 (0.43) FGFR4FGFR1FGFR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3524603-B1 FGFR4 INHIBITOR, PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF ABBISKO THERAPEUTICS CO LTD (CN) 2022-06-08 — — EP disclosed
EP-3524603-A1 FGFR4 INHIBITOR, PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF Abbisko Therapeutics Co., Ltd. (CN) 2019-08-14 — — EP disclosed
Send feedback